Rapid Regression of Neurological Symptoms in Patients With Metastasised ALK+ Lung Cancer Who Are Treated With Lorlatinib: A Report of Two Cases
BMJ Case Reports - United Kingdom
doi 10.1136/bcr-2018-227299
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 1, 2019
Authors
Publisher
BMJ